Albanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Faqja 1 nga 39 rezultatet
Tumor imaging compounds
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
The development of radiolabeled amino acids for use as metabolic tracers to image tumors using positron emission tomography (PET) and single photon emission computed tomography (SPECT) has been underway for two decades. Although radiolabeled amino acids have been applied to a variety of tumor types,
Tumor imaging compounds
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
The development of radiolabeled amino acids for use as metabolic tracers to image tumors using positron emission tomography (PET) and single photon emission computed tomography (SPECT) has been underway for two decades. Although radiolabeled amino acids have been applied to a variety of tumor types,
Modulators of the p70S6 kinase for use in the treatment of brain disorders and triple-negative breast cancer
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a national stage filing under section 371 of International Application No. PCT/EP2016/053172, filed on Feb. 15, 2016, and published on Aug. 25, 2016 as WO 2016/131776, which claims priority to Great Britain Application No. 1502567.9, filed
Amino acid analogs for tumor imaging
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
FIELD OF THE INVENTION
The invention includes novel chemical compounds having specific binding in a biological system and capable of being used for positron emission tomography (PET) and single photon emission (SPECT) imaging methods.
BACKGROUND OF THE INVENTION
The ability of analog compounds to
Amino acid analogs for tumor imaging
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
FIELD OF THE INVENTION
The invention includes novel chemical compounds having specific binding in a biological system and capable of being used for positron emission tomography (PET) and single photon emission (SPECT) imaging methods.
BACKGROUND OF THE INVENTION
The ability of analog compounds to
Treatment of neoplasms in the brain with diamino dichloroalkyl pyrimidine
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
BACKGROUND OF THE DISCLOSURE
This invention relates to a method of treating meningeal leukemia and CNS lymphoma and neoplasms in the brain in man and pharmaceutical preparations suitable for such use.
More effective antileukemic therapy and consequent longer survival has the unfortunate consort of
Pyranone derivatives useful for treating cancer
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
This application is a National Stage application of PCT/FR2005/000084, filed Jan. 14, 2005, which claims priority from French patent application FR 0400298, filed Jan. 14, 2004. The entire contents of each of the aforementioned applications are incorporated herein by reference.
The subject of the
Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
The present invention relates to the use of substituted acryloyl distamycin derivatives, in particular to the use of .alpha.-bromo- and .alpha.-chloroacryloyl distamycin derivatives, in the treatment of tumors associated with high levels of glutathione and/or glutathione-S-transferases family.
More
DC-89 derivatives as anti-tumor agents
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
BACKGROUND OF THE INVENTION
The present invention relates to DC-89 derivatives. The compounds have an excellent anti-tumor activity and are useful as anti-tumor agents.
As compounds structurally similar to the DC-89 derivatives of the present invention, those represented by the following structure
Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and platinum derivatives
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
CROSS-REFERENCE TO RELATED APPLICATION
This application is a National Stage entry of International Application No. PCT/EP01/07064, filed Jun. 20, 2001, the entire specification claims and drawings of which are incorporated herewith by reference.
The present invention relates to the field of cancer
14-acyloxy-2'-halo-anthracycline anti-cancer antibiotics
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
BACKGROUND OF THE INVENTION
Anthracyline antibiotics including doxorubicin, daunorubicin, and carminomycin are important chemotherapeutic agents in the treatment of a broad spectrum of neoplastic conditions including acute myeloblastic and lymphoblastic leukemias. Doxorubicin (also known as
14-Acyloxy-2'-halo-anthracycline anti-cancer antibiotics
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
BACKGROUND OF THE INVENTION
Anthracyline antibiotics including doxorubicin, daunorubicin, and carminomycin are important chemotherapeutic agents in the treatment of a broad spectrum of neoplastic conditions including acute myeloblastic and lymphoblastic leukemias. Doxorubicin (also known as
Nitrogen mustard prodrugs with novel lipophilic protecting groups, and processes for their production
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
The present invention relates to prodrugs and their use in the treatment of disease, including cancers.
The use of prodrugs represents a clinically very valuable concept in cancer therapy since. particularly where the prodrug is to be converted to an anti-tumour agent under the influence of an
Inhibitor of casein kinase 1delta and casein kinase 1E
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
TECHNICAL FIELD
The present invention relates to an inhibitor of casein kinase 1.delta. and casein kinase 1.epsilon., which comprises, as an active ingredient, an oxazolone derivative, a salt thereof, a solvate thereof, or a hydrate thereof. The present invention relates to a pharmaceutical agent
Imaging agents
Vetëm përdoruesit e regjistruar mund të përkthejnë artikuj
Identifikohuni Regjistrohu
BACKGROUND OF THE INVENTION
This invention relates to novel amino acid analogs having specific and selective binding in a biological system, particularly brain and systemic tumors, and capable of being used for positron emission tomography (PET) and single photon emission (SPECT) imaging
Baza e të dhënave më e plotë e bimëve medicinale e mbështetur nga shkenca
- Punon në 55 gjuhë
- Kurime bimore të mbështetura nga shkenca
- Njohja e bimëve nga imazhi
- Harta GPS interaktive - etiketoni bimët në vendndodhje (së shpejti)
- Lexoni botime shkencore në lidhje me kërkimin tuaj
- Kërkoni bimë medicinale nga efektet e tyre
- Organizoni interesat tuaja dhe qëndroni në azhurnim me kërkimet e lajmeve, provat klinike dhe patentat
Shkruani një simptomë ose një sëmundje dhe lexoni në lidhje me barërat që mund të ndihmojnë, shtypni një barishte dhe shikoni sëmundjet dhe simptomat që përdoren kundër.
* I gjithë informacioni bazohet në kërkimin shkencor të botuar
